Marth T
Deutsche Klinik für Diagnostik, Aukammallee 33, 65191 Wiesbaden, Germany.
Curr Allergy Asthma Rep. 2001 Nov;1(6):566-71. doi: 10.1007/s11882-001-0066-7.
Whipple's disease is a rare, chronic, and systemic infectious disease caused by the ubiquitously occurring bacterium Tropheryma whippelii. For two reasons, the disease represents a good example for documenting the input of modern molecular-based techniques into pathogenetic, diagnostic, and therapeutic concepts in clinical medicine. First, the unidentified and uncultivable causative organism has been characterized by novel molecular-genetic techniques. Second, in contrast to other chronic inflammatory disorders, clinical manifestations of T. whippelii infection seem to be based on reduced T-cell helper type 1 (TH1) activity. These findings have led to an improved pathophysiologic understanding of the disease and to new aspects in treatment strategies that are discussed in this paper.
惠普尔病是一种罕见的慢性全身性传染病,由普遍存在的细菌惠普尔嗜组织菌引起。由于两个原因,该疾病是一个很好的例子,可用于记录现代分子技术在临床医学的发病机制、诊断和治疗概念中的应用。首先,这种尚未鉴定且无法培养的病原体已通过新型分子遗传学技术得以表征。其次,与其他慢性炎症性疾病不同,惠普尔嗜组织菌感染的临床表现似乎基于辅助性T细胞1型(TH1)活性降低。这些发现使人们对该疾病的病理生理学有了更好的理解,并为本文所讨论的治疗策略带来了新的思路。